Proactive Investors - Run By Investors For Investors

Kromek Group undergoing a commercial transformation as forecasts 40% growth in revenues

The company, headquartered in Durham, is now reaping the rewards of two years hard work as it is delivering the orders it has generated in that time
Kromek Group undergoing a commercial transformation as forecasts 40% growth in revenues
The company's radiation detection units have been shipped in bulk to the US

Kromek Group PLC (LON:KMK), the maker of radiation detection technology used in medical devices and security, said it is seeing a “step change” across the business with revenues expected grow 40% in the current year – in line with previous forecasts.

The company, headquartered in Durham, is now reaping the rewards of two years hard work as it is delivering the orders it has generated in that time.

In medical imaging, where its technology is incorporated into diagnostic systems, it has secured a £9.8mln (US$12.6mln), five-year contract along with a number of other deals, while the security operation has hammered down a separate five-year deal, this time worth least £2.4mln (US$3.1mln).

WATCH:'This is the year Kromek turns a financial corner' - CEO Dr Arnab Basu

Nuclear detection doing well

Kromek’s nuclear detection business, meanwhile, has delivered 10,000 of its D3S radiation units to the US Defense Research Projects Agency’s Sigma project, which is there to head off the threat of nuclear terrorism. The order is a huge tick in the box of the company’s devices, analysts said.

In January it raised £21mln from investors which has allowed it to tap into the huge market opportunities and to invest in research and development, which keeps the company at the cutting edge of radiation technology.

In the year ended April 30 Kromek generated revenues of £8.7mln, up from £8.3mln. As might be expected from a business setting out on the commercial phase of its development, it was loss-making – to the tune of £1.5mln.

High performance radiation detection

The company is the developer of high performance radiation detection products based on cadmium zinc telluride and other advanced technologies.

Using its core platforms, Kromek designs, develops and produces x-ray and gamma photon imaging and radiation detection products for the medical, security screening and nuclear markets.

They provide high resolution information on material composition and structure.

This means they can be used in many applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

Vertically integrated

Kromek operates a vertically integrated technology. What this means practically is it offers customers core technology components as well finished products such detectors, including software, electronics and application specific integrated circuits.

While based in the north-east, the business, which employs 100, has operations in California and Pennsylvania and sells internationally through distributors and direct to manufacturers.

 

View full KMK profile View Profile

Kromek Group PLC Timeline

Related Articles

Iran sanctions cartoon
September 21 2018
The group has been providing baggage screening services at Freetown International Airport in Sierra Leone for the past five years
Crops
December 05 2018
Markets for both antennas and water systems are set to grow strongly over the coming years
The Internet of Things
September 04 2018
"We have seen double-digit revenue growth, improved gross margins from H2 2017 and our cost optimisation plan is well underway," said Yosi Fait, Telit's CEO

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use